Chapter 7. Vascular Proliferative Disease

作者: Larry A. Denner , Richard A.F. Dixon

DOI: 10.1016/S0065-7743(08)60920-3

关键词:

摘要: Publisher Summary The most common initial form of vascular proliferative disease is atherosclerosis, a occlusive event that occurs over the course many years or decades as consequence abnormal cholesterol deposition in vessel walls. normal primary function blood vessels to carry nutrients and oxygen capillary beds metabolic products carbon dioxide for removal from body. Natural defense systems have evolved insure control these functions. These include platelet adhesion at luminal surface injured walls induce formation thrombi lead clot prevention bleeding into extravascular space. In case extensive insults wall, inflammatory cells also accumulate aid repair. Under certain conditions, protective mechanisms are overstimulated cause diseases; being atherosclerosis. treatments diseases numerous diverse, including percutaneous transluminal coronary angioplasty (PTCA balloon angioplasty), bypass interpositional grafting, carotid endarterectomy, hemodialysis access grafts, transplant, stents. Treatments, while initially often successful, secondary narrowing called restenosis. Reduction disease, such restenosis, very complex challenge related heterogeneous expression this disease. While sharing features occlusion, typically result smooth muscle (SMC) proliferation matrix encroach on lumen, restenotic initiated by wide variety stimuli. Further, stimuli occur redundant but distinct processes.

参考文章(71)
Annette M. Doherty, Joan A. Keiser, Chapter 10. Growth Factors in Cardiovascular Disease Annual Reports in Medicinal Chemistry. ,vol. 28, pp. 89- 98 ,(1993) , 10.1016/S0065-7743(08)60880-5
F T Thandroyen, M D Phillips, D D'Souza, L M Buja, A 24-year-old man with extensive lower limb edema and acute arterial occlusion. Circulation. ,vol. 90, pp. 2115- 2123 ,(1994) , 10.1161/01.CIR.90.4.2115
Isabella T. Tai, Anthony M. Sun, Microencapsulation of recombinant cells: a new delivery system for gene therapy. The FASEB Journal. ,vol. 7, pp. 1061- 1069 ,(1993) , 10.1096/FASEBJ.7.11.8370477
Alfredo E. Rodriguez, Omar Santaera, Miguel Larribau, Mario Fernandez, Ricardo Sarmiento, Nestor Perez Baliño, John B. Newell, Gary S. Roubin, Igor F. Palacios, Coronary Stenting Decreases Restenosis in Lesions With Early Loss in Luminal Diameter 24 Hours After Successful PTCA Circulation. ,vol. 91, pp. 1397- 1402 ,(1995) , 10.1161/01.CIR.91.5.1397
A Fernández-Ortiz, B J Meyer, A Mailhac, E Falk, L Badimon, J T Fallon, V Fuster, J H Chesebro, J J Badimon, A new approach for local intravascular drug delivery. Iontophoretic balloon. Circulation. ,vol. 89, pp. 1518- 1522 ,(1994) , 10.1161/01.CIR.89.4.1518
E. Hoberg, R. Dietz, U. Frees, H. A. Katus, B. Rauch, A. Schomig, G. Schuler, F. Schwarz, H. Tillmanns, J. Niebauer, Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Heart. ,vol. 71, pp. 254- 260 ,(1994) , 10.1136/HRT.71.3.254
Edward R. O'Brien, Stephen M. Schwartz, Update on the biology and clinical study of restenosis Trends in Cardiovascular Medicine. ,vol. 4, pp. 169- 178 ,(1994) , 10.1016/1050-1738(94)90054-X
U Dietz, R Erbel, H J Rupprecht, S Weidmann, J Meyer, High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions. Heart. ,vol. 70, pp. 327- 336 ,(1993) , 10.1136/HRT.70.4.327
D A Healy, A W Clowes, R E Zierler, S C Nicholls, R O Bergelin, J F Primozich, D E Strandness, Immediate and long-term results of carotid endarterectomy. Stroke. ,vol. 20, pp. 1138- 1142 ,(1989) , 10.1161/01.STR.20.9.1138